» Articles » PMID: 18063075

Utilization of Total Thyroidectomy for Papillary Thyroid Cancer in the United States

Overview
Journal Surgery
Specialty General Surgery
Date 2007 Dec 8
PMID 18063075
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite guidelines that recommend total thyroidectomy for papillary thyroid cancer (PTC) greater than or equal to 1 cm, the extent of surgery remains controversial. We examined surgical practice patterns for PTC greater than or equal to 1 cm and identified factors that predict the use of total thyroidectomy.

Methods: Of 90,382 patients in the National Cancer Center Data Base (NCDB) with PTC from 1985 to 2003, 57,243 patients had tumors greater than or equal to 1 cm and underwent total thyroidectomy or lobectomy. Trends in extent of surgery for PTC were examined over 2 decades. Logistic regression was used to identify factors that predict use of total thyroidectomy compared with lobectomy.

Results: Use of total thyroidectomy increased from 70.8% in 1985 to 90.4% in 2003 (P < .0001). Patients were less likely to undergo total thyroidectomy if they were black, older than 45 years, had Medicare, had lower household incomes, or had less education (P < .0001). Moreover, patients treated at high-volume or academic centers were more likely to undergo total thyroidectomy than were patients examined at low-volume or community hospitals (P < .0001).

Conclusions: Use of total thyroidectomy for PTC greater than or equal to 1 cm increased over time. Differences in use of total thyroidectomy are related to patient, tumor, and hospital factors and likely reflect disparities in access to care.

Citing Articles

Impact of fine-needle aspiration cytology in thyroidectomy extent and associated surgical morbidity in thyroid cancer.

Lind P, Nordenstrom E, Johansson L, Wallin G, Daskalakis K Langenbecks Arch Surg. 2024; 409(1):68.

PMID: 38374242 PMC: 10876808. DOI: 10.1007/s00423-024-03258-3.


Evolving variation in the extent of surgery for low-risk papillary thyroid cancer in the United States.

Montgomery K, Fazendin J, Broman K Surgery. 2023; 174(4):828-835.

PMID: 37550165 PMC: 10529036. DOI: 10.1016/j.surg.2023.07.001.


Prognostic Utility of Tumor Stage versus American Thyroid Association Risk Class in Thyroid Cancer.

Abiri A, Pang J, Prasad K, Goshtasbi K, Kuan E, Armstrong W Laryngoscope. 2022; 133(1):205-211.

PMID: 35716358 PMC: 9759623. DOI: 10.1002/lary.30252.


Age-based disparities in the use of total thyroidectomy for papillary thyroid carcinoma.

Shevchyk I, Cobian B, Martinez S Clin Transl Oncol. 2017; 19(10):1253-1259.

PMID: 28439795 DOI: 10.1007/s12094-017-1663-9.


National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.

Chang E, Lutfi W, Feinglass J, Reiher A, Moo-Young T, Bhayani M World J Surg. 2016; 40(12):2930-2940.

PMID: 27447700 DOI: 10.1007/s00268-016-3643-6.